Company profile for Psycheceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We're removing barriers to care by employing state-of-the-art patented delivery technologies to provide safe and effective psychedelic pharmaceutical medicines. Using state-of-the-art delivery technologies to provide safe and effective psychedelic pharmaceutical medicines.Our visionary team of industry experts has 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutic...
We're removing barriers to care by employing state-of-the-art patented delivery technologies to provide safe and effective psychedelic pharmaceutical medicines. Using state-of-the-art delivery technologies to provide safe and effective psychedelic pharmaceutical medicines.Our visionary team of industry experts has 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutical industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
515 E. Las Olas Blvd Suite 120 Fort Lauderdale, FL 33301
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/psycheceutical-bioscience-inc-named-a-2023-top-10-biotech-startup-by-life-sciences-review-301796857.html

PR NEWSWIRE
13 Apr 2023

https://www.globenewswire.com/news-release/2023/03/29/2637071/0/en/Psycheceutical-Hosts-MAPS-Founder-and-Psychedelic-Industry-Leader-Rick-Doblin-at-Its-Drug-Development-Lab.html

GLOBENEWSWIRE
29 Mar 2023

https://www.globenewswire.com/news-release/2023/03/21/2631698/0/en/Psycheceutical-Bioscience-Inc-Announces-Observational-Research-Results-for-NeuroDirect-Ketamine-Topical-Cream-in-Treating-PTSD.html

GLOBENEWSWIRE
21 Mar 2023

https://www.globenewswire.com/news-release/2023/02/15/2609017/0/en/Psycheceutical-to-Conduct-the-First-Ever-Phase-I-and-II-Clinical-Trials-of-a-Novel-Ketamine-Topical-Cream-to-Treat-PTSD.html

GLOBENEWSWIRE
15 Feb 2023

https://www.globenewswire.com/news-release/2023/02/02/2600676/0/en/Psycheceutical-Announces-Completion-of-Pre-IND-Meeting-with-FDA-for-Topical-Ketamine-Drug-to-Treat-PTSD.html

GLOBENEWSWIRE
02 Feb 2023

https://www.globenewswire.com/news-release/2023/01/26/2596339/0/en/Psycheceutical-Bioscience-Provisional-Patent-Application-for-Novel-Ketamine-Topical-for-the-Treatment-of-PTSD.html

GLOBENEWSWIRE
26 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty